The finding that MBCs associated with BRCA1 mutations are frequently ER+ suggests that the hormonal milieu may be a mechanism controlling ER status in BRCA1 tumours. The gene discussed is BRCA1; the disease is maternal uniparental disomy of chromosome 20.